Xi-Yong Yu

1.1k total citations
15 papers, 922 citations indexed

About

Xi-Yong Yu is a scholar working on Molecular Biology, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Xi-Yong Yu has authored 15 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Surgery and 3 papers in Complementary and alternative medicine. Recurrent topics in Xi-Yong Yu's work include Ginseng Biological Effects and Applications (3 papers), Extracellular vesicles in disease (3 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Xi-Yong Yu is often cited by papers focused on Ginseng Biological Effects and Applications (3 papers), Extracellular vesicles in disease (3 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Xi-Yong Yu collaborates with scholars based in China, United States and Australia. Xi-Yong Yu's co-authors include Yangxin Li, Lin Shu-guang, Yong‐Jian Geng, Zhi‐Xin Shan, Lianbo Shao, Yu Zhang, Lulu Zhang, Qingyou Meng, Juanjuan Wang and Yao-Hua Song and has published in prestigious journals such as ACS Nano, Biochemical and Biophysical Research Communications and Experimental Cell Research.

In The Last Decade

Xi-Yong Yu

15 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi-Yong Yu China 13 564 248 212 121 115 15 922
Yong‐Heng Fu China 20 769 1.4× 484 2.0× 133 0.6× 70 0.6× 272 2.4× 37 1.2k
Zheng Gen Jin United States 24 825 1.5× 252 1.0× 117 0.6× 29 0.2× 177 1.5× 39 1.4k
Yong Tang China 17 602 1.1× 380 1.5× 74 0.3× 45 0.4× 128 1.1× 40 1.0k
Hongxin Cheng China 8 355 0.6× 121 0.5× 133 0.6× 42 0.3× 235 2.0× 19 757
Yühong Huang China 10 521 0.9× 152 0.6× 63 0.3× 62 0.5× 93 0.8× 19 1.1k
Wei Eric Wang China 19 813 1.4× 224 0.9× 281 1.3× 29 0.2× 335 2.9× 46 1.3k
Xian Jin China 14 569 1.0× 229 0.9× 148 0.7× 26 0.2× 159 1.4× 31 1.1k
Yi Fu China 17 329 0.6× 155 0.6× 72 0.3× 44 0.4× 63 0.5× 44 898
Xiaoguang Zhu China 17 446 0.8× 175 0.7× 66 0.3× 21 0.2× 120 1.0× 31 839
Courtney Cates United States 15 687 1.2× 145 0.6× 178 0.8× 36 0.3× 367 3.2× 20 1.3k

Countries citing papers authored by Xi-Yong Yu

Since Specialization
Citations

This map shows the geographic impact of Xi-Yong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi-Yong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi-Yong Yu more than expected).

Fields of papers citing papers by Xi-Yong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi-Yong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi-Yong Yu. The network helps show where Xi-Yong Yu may publish in the future.

Co-authorship network of co-authors of Xi-Yong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xi-Yong Yu. A scholar is included among the top collaborators of Xi-Yong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi-Yong Yu. Xi-Yong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Liang, Lu, Weijie Peng, Aiping Qin, et al.. (2024). Intracellularly Synthesized Artificial Exosome Treats Acute Lung Injury. ACS Nano. 18(32). 21009–21023. 13 indexed citations
2.
Yan, Yan‐yan, Hong Ji, Hui Wang, et al.. (2021). Microfluidics applications for high-throughput single cell sequencing. Journal of Nanobiotechnology. 19(1). 312–312. 80 indexed citations
3.
Song, Yao-Hua, Lianbo Shao, Jin Zhou, et al.. (2017). Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases. Advances in experimental medicine and biology. 998. 187–206. 12 indexed citations
4.
Shao, Lianbo, Yu Zhang, Juanjuan Wang, et al.. (2017). MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair. BioMed Research International. 2017. 1–9. 246 indexed citations
5.
Li, Qianqian, Lin Jiang, Chunyu Deng, et al.. (2015). Generation of Functional Human Cardiac Progenitor Cells by High-Efficiency Protein Transduction. Stem Cells Translational Medicine. 4(12). 1415–1424. 36 indexed citations
6.
Yu, Xi-Yong, Yong‐Jian Geng, Jialiang Liang, et al.. (2012). High levels of glucose induce “metabolic memory” in cardiomyocyte via epigenetic histone H3 lysine 9 methylation. Molecular Biology Reports. 39(9). 8891–8898. 51 indexed citations
7.
Huang, Wei, Tao Wang, Dongsheng Zhang, et al.. (2011). Mesenchymal Stem Cells Overexpressing CXCR4 Attenuate Remodeling of Postmyocardial Infarction by Releasing Matrix Metalloproteinase-9. Stem Cells and Development. 21(5). 778–789. 47 indexed citations
8.
Yu, Xi-Yong, Yong-Jian Geng, Jialiang Liang, et al.. (2010). High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Experimental Cell Research. 316(17). 2903–2909. 48 indexed citations
9.
Huang, Ge, et al.. (2010). Molecular Characterization of a Chinese Pedigree with β-Thalassemia Intermedia. Hemoglobin. 34(2). 179–183. 2 indexed citations
10.
Yu, Xi-Yong, Yao-Hua Song, Yong‐Jian Geng, et al.. (2008). Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochemical and Biophysical Research Communications. 376(3). 548–552. 148 indexed citations
11.
Yu, Xi-Yong, Lin Shu-guang, Zhi-Wei Zhou, et al.. (2007). Role of P-Glycoprotein in the Intestinal Absorption of Tanshinone IIA, a Major Active Ingredient in the Root of Salvia miltiorrhiza Bunge. Current Drug Metabolism. 8(4). 325–340. 61 indexed citations
12.
Yu, Xi-Yong, Lin Shu-guang, Xiaohong Chen, et al.. (2007). Transport of Cryptotanshinone, a Major Active Triterpenoid in Salvia Miltiorrhiza Bunge Widely Used in the Treatment of Stroke and Alzheimers Disease, Across the Blood-Brain Barrier. Current Drug Metabolism. 8(4). 365–377. 75 indexed citations
13.
Huang, Yü, et al.. (2007). The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Regulatory Peptides. 144(1-3). 109–114. 36 indexed citations
14.
Yu, Xi-Yong, Lin Shu-guang, Zhi-Wei Zhou, et al.. (2007). Role of P-glycoprotein in Limiting the Brain Penetration of Glabridin, An Active Isoflavan from the Root of Glycyrrhiza glabra. Pharmaceutical Research. 24(9). 1668–1690. 29 indexed citations
15.
Yu, Xi-Yong, Lin Shu-guang, Zhi-Wei Zhou, et al.. (2007). Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats. Neuroscience Letters. 417(3). 261–265. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026